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Abstract
Background: The number needed to treat (NNT) is a well-known effect measure for reporting
the results of clinical trials. In the case of time-to-event outcomes, the calculation of NNTs is more
difficult than in the case of binary data. The frequency of using NNTs to report results of
randomised controlled trials (RCT) investigating time-to-event outcomes and the adequacy of the
applied calculation methods are unknown.
Methods:  We searched in PubMed for RCTs with parallel group design and individual
randomisation, published in four frequently cited journals between 2003 and 2005. We evaluated
the type of outcome, the frequency of reporting NNTs with corresponding confidence intervals,
and assessed the adequacy of the methods used to calculate NNTs in the case of time-to-event
outcomes.
Results: The search resulted in 734 eligible RCTs. Of these, 373 RCTs investigated time-to-event
outcomes and 361 analyzed binary data. In total, 62 articles reported NNTs (34 articles with time-
to-event outcomes, 28 articles with binary outcomes). Of the 34 articles reporting NNTs derived
from time-to-event outcomes, only 17 applied an appropriate calculation method. Of the 62
articles reporting NNTs, only 21 articles presented corresponding confidence intervals.
Conclusion: The NNT is used as effect measure to present the results from RCTs with binary
and time-to-event outcomes in the current medical literature. In the case of time-to-event data
incorrect methods were frequently applied. Confidence intervals for NNTs were given in one third
of the NNT reporting articles only. In summary, there is much room for improvement in the
application of NNTs to present results of RCTs, especially where the outcome is time to an event.
Background
The concept of the number needed to treat (NNT) was
proposed by Laupacis et al. [1] in 1988 to provide clini-
cians with a useful measure of treatment benefit. It repre-
sents the average number of patients who must be treated
to prevent one adverse outcome within a certain duration
of follow-up time, and is calculated by inverting the abso-
lute risk reduction (ARR) [1,2]. There is an intensive dis-
cussion about the comprehensibility and the usefulness of
NNTs in the scientific literature [3-11]. The main mathe-
matical arguments against the use of NNTs, namely unde-
sirable distributional properties and that NNT is
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undefined if ARR = 0, are justified. However, mathemati-
cal arguments lose their importance when NNT is consid-
ered just as a way to translate research results to patients,
not as a tool for statistical computations [3,12]. It is also
questioned by several authors whether NNTs are intui-
tively meaningful and helpful for physicians and patients
[7-10]. Nevertheless, in the past years, the number needed
to treat has become a well-known effect measure and is
conventionally applied in randomised controlled trials
(RCTs) with a binary outcome where the duration of fol-
low-up time is fixed and the time to event plays no role or
is ignored [12]. In 2001, the explanatory document of the
Consolidated Standards of Reporting Trials (CONSORT)
statement noted that NNTs could be helpful in expressing
results for both binary and survival time data [13].
In RCTs with a binary outcome the calculation of NNTs is
based on simple proportions referring to the fixed dura-
tion of follow-up (i.e. rates from a 2 × 2 table) [1,2,12]. In
the case of time-to-event outcomes, the calculation of the
number needed to treat is more difficult because varying
follow-up times and censoring have to be taken into
account [12].
Two basic methods have been proposed to calculate the
number needed to treat in this situation. Altman &
Andersen [14] proposed to calculate NNTs for one or sev-
eral fixed time points based on survival probabilities esti-
mated by the Kaplan-Meier survival curve or the Cox
regression model. Due to the dependency on time, ARRs
and NNTs refer to specific time points. A time specific
NNT(t) is interpreted as the average number of patients
needed to be treated to observe one event-free patient
more in the treatment group than in the control group at
time point t.
A second method was proposed by Lubsen et al. [15] and
Mayne et al. [16], independently of each other. In both
papers, it was proposed to use the reciprocal of the hazard
difference rather than the risk difference to estimate NNTs
for time-to-event outcomes. An argument for using haz-
ards was that a distinction has to be made between trials
of acute conditions with treatments of a short fixed dura-
tion and trials of chronic diseases and continuous treat-
ments [15]. It was argued that in the case of chronic
diseases and continuous treatments the calculation of
NNTs by inverting the hazard difference would be more
appropriate because an expression in units of person-time
is required [15]. However, the NNT is an effect measure to
quantify the impact of a treatment in terms of patient
numbers that have to be treated to avoid one event within
a certain length of follow-up time. The reciprocal of the
hazard difference results in the average number of patient
years (instead of patients) needed to observe one event
less in the treatment group than in the control group.
However, this explanation is only valid in the case of a
constant hazard difference, i.e. if the distribution of the
survival times is given by the exponential distribution
[16] or the linear hazard rate distribution [17]. For all
other survival time distributions the hazard difference and
its reciprocal are time dependent. Moreover, the hazard
difference is only a valid approximation of the risk differ-
ence if event rates are low, for instance less than 5%
[16,18]. In all other cases the use of hazards to calculate
NNTs is misleading. Therefore, in this paper the NNT is –
as usual – considered as effect measure comparing the
risks of two groups (treatment versus control) for a spe-
cific length of follow-up time in terms of patient numbers
having to be treated to expect an avoided event in one
patient.
Nuovo et al. [19] investigated the frequency of reporting
NNTs in RCTs published in leading medical journals in
the years 1989, 1992, 1995, and 1998. They found that
only about 2% of eligible articles reported NNTs and con-
cluded that this effect measure was underused in the med-
ical literature.
The main objectives of our review are to investigate the
frequency of reporting NNTs in RCTs published in leading
medical journals in the years 2003–2005 and to assess
whether the methods applied for their calculation were
appropriate in the case of time-to-event outcomes. We
also assessed whether confidence intervals were reported
to describe the uncertainty of the estimated NNT meas-
ures for both time-to-event and binary outcomes.
Methods
Articles published in the years 2003 to 2005 in the follow-
ing four frequently cited journals were evaluated: BMJ,
JAMA, New England Journal of Medicine (NEJM), and Lan-
cet. The search was limited to articles with available
abstracts and publication date 2003/01/01 to 2005/12/
31. In a first step, each journal was searched using
PubMed to identify articles reporting results of RCTs. Eli-
gible articles included single studies that reported a paral-
lel group design and an individual randomisation
process; other articles were excluded (Figure 1). All titles
and abstracts of the retrieved articles were screened to
exclude obviously non-eligible articles. In a second step,
the full texts of all eligible articles were then analysed to
identify RCTs presenting NNTs (for any outcome) and
RCTs investigating time-to-event outcomes. The articles
were screened using the text search function. The terms
used to identify the number needed to treat were
"number", "need", "treat", and "NNT". The terms used to
identify survival time data were: "survival", "Kaplan",
"Cox", "life", and "time". If the screening results were neg-
ative or unclear, the methods sections of the articles were
also reviewed manually to identify any use of NNTs and
survival data.BMC Medical Research Methodology 2009, 9:21 http://www.biomedcentral.com/1471-2288/9/21
Page 3 of 7
(page number not for citation purposes)
We assessed, whether the methods used to calculate NNTs
from time-to-event outcomes were appropriate. Accord-
ing to the methodology described in the literature [12,14-
16,18] we considered a method as appropriate if the NNT
was calculated either from survival probabilities estimated
by means of the Kaplan-Meier method or the Cox regres-
sion model [14] or if it was calculated as the inverse of the
hazard difference and both assumptions mentioned
above are met (constant hazard difference and low event
rates) [15,16,18]. When the method to calculate NNTs
was not described in the article, we tried to verify the
reported NNTs by recalculation from the presented data.
The use of an appropriate method to calculate NNTs was
possible if the corresponding Kaplan-Meier survival or
incidence curves were presented. In this case we were able
to recalculate the NNT as follows. At first we identified the
point of time at which the NNT was estimated. If no time
point was given we used the latest time point of the Kap-
lan-Meier graph. From this time point we draw a vertical
line to the top of the graph so that the curves of the treat-
ment arms were crossed. From these cross points we draw
horizontal lines to the y-axis and read off the correspond-
ing survival probabilities for the different treatment arms
as accurate as possible. These probabilities were then used
for NNT calculation. When it was clear that an inappropri-
ate method was used either by statements given in the text
or by comparing the presented with the recalculated NNT,
the method was classified as "inappropriate", otherwise as
"appropriate".
We also assessed whether confidence intervals for the
number needed to treat were provided. If the numbers at
risk were given together with the Kaplan-Meier curve or
were inferable because of lost-to-follow-up information
or a hazard ratio with confidence interval was presented
we were able to calculate also a confidence interval for the
recalculated NNT by using one of methods proposed by
Altman & Andersen [14]. If numbers at risk were given but
not exactly for the required time point we used the num-
bers at risk for the corresponding nearest time point.
Additionally, we investigated the reporting of absolute
risk reduction with corresponding confidence interval. To
characterise the studies we further evaluated the median
sample size of the studies reporting NNTs and whether the
outcome for which the NNT was calculated was a primary
or secondary endpoint.
Results
A total of 808 articles were initially retrieved in the
PubMed search, of which 734 met the inclusion criteria.
Figure 1 shows the flow chart of this literature review. Of
the eligible articles, 62 (8.4%) reported a number needed
to treat (Table 1). One article used the method proposed
by Lubsen et al. [15] but described the results as "number
of patient years of treatment to save one life" and not as
"NNT" or "number of patients ...". Thus, this article was
classified as non-NNT-reporting article. The 62 NNT-
reporting articles had a median sample size of 553, rang-
ing from 47 to 12639. Furthermore, 56 of 62 (90.3%) arti-
cles calculated the number needed to treat for the primary
endpoint, 5 (8.1%) for primary and secondary endpoints,
and 1 study (1.6%) calculated the number needed to treat
only for a secondary outcome. The distribution of the 734
articles across the four considered journals BMJ, JAMA,
Lancet, and NEJM was 90, 199, 190, and 255 (Table 1). As
the results indicated no trend over the three years we do
not show the results of the single years. NEJM published
the largest number of RCTs but had the lowest use of
NNTs (19 of 255 articles), whereas the BMJ with the least
number of RCTs represented the journal with the highest
use of NNTs (13 of 90 articles). The BMJ was the journal
Study selection procedure to identify randomised controlled  trials (RCTs) reporting the number needed to treat (NNT)  in leading medical journals in the years 2003–2005 Figure 1
Study selection procedure to identify randomised 
controlled trials (RCTs) reporting the number 
needed to treat (NNT) in leading medical journals in 
the years 2003–2005.
Table 1: Reporting of the number needed to treat (NNT) and 
corresponding 95% confidence interval (CI) in randomised 
controlled trials (RCTs) in leading medical journals in the years 
2003–2005
No. of articles
Journal RCTs NNT reporting CI for NNT
BMJ 90 13 7
JAMA 199 16 4
Lancet 190 14 4
NEJM 255 19 6
Total 734 62 (8.4%) 21 (33.9%)BMC Medical Research Methodology 2009, 9:21 http://www.biomedcentral.com/1471-2288/9/21
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with the largest percentage of articles presenting confi-
dence intervals for NNT estimates (7 of 13, 53.8%).
Time-to-event outcomes were investigated in 373 (51%)
articles; the other 361 articles used binary outcomes. In 3
articles, survival techniques as well as 2 × 2 tables were
used for data analysis. The use of both methods was ade-
quate in these articles because the follow-up time was
equal for all patients and no censoring occurred. As NNTs
were calculated on the basis of 2 × 2 tables these articles
were classified as RCTs using binary outcomes. Of the 62
articles reporting NNTs, 34 articles presented time-to-
event outcomes and 28 presented binary outcomes. Of
the 34 NNT-reporting articles with time-to-event out-
comes, only 17 (50%) applied an appropriate calculation
method (Table 2). In all these articles, the NNT calcula-
tion was clearly based on estimated survival probabilities
by means of the Kaplan-Meier survival curve or the Cox
regression model or the reported NNT equalled our recal-
culated NNT. In the remaining 17 (50%) of the 34 NNT-
reporting articles with time-to-event outcomes the calcu-
lation was seemingly based on naive proportions (rates
from 2 × 2 tables). This approach neglects varying follow-
up times and censoring and was therefore classified as
inappropriate. If possible, we recalculated the NNT based
upon estimated survival probabilities. In Table 3 the pub-
lished and recalculated NNTs of the 17 articles with 95%
confidence intervals (if recalculation was possible) and
the corresponding absolute differences are summarized. A
table providing some details (citation, experimental and
control intervention, outcomes, sample size, follow-up
time, published NNT, and corresponding 95% confidence
interval) of the 34 NNT-reporting articles with time-to-
event outcomes is given as Additional file 1.
To explain the methods of our calculations we present one
typical example. One study provided the information
"The number needed to treat to prevent 1 cardiovascular
event would be 40 patients with IGT over 3.3 years". Addi-
tionally, the naive proportions of patients experiencing an
event were given as 32/686 in the placebo group and 15/
682 in the intervention group. Obviously, the result of
NNT = 40 is based upon these naive proportions, because
1/(32/686-15/682)≈1/0.025 = 40. However, due to vary-
ing follow-up times and censoring, the naive proportions
represent no valid estimates of the corresponding risks at
time point 3.3 years, which is only the mean follow-up
time. An adequate approach to estimate the required risks
for a specified time point is given by the Kaplan-Meier
method.
We enlarged the Kaplan-Meier incidence curve given in
the paper and determined the corresponding risk esti-
mates at time point 1200 days visually as accurate as pos-
sible. We found the risk values 0.0410 and 0.0235 for the
placebo and the intervention group, respectively. Thus,
the recalculated NNT is given by 1/(0.0410 - 0.0235) = 1/
0.0175 = 57.1 and the reported NNT of 40 is about 30%
too low.
In the 62 NNT-reporting articles, corresponding confi-
dence intervals were presented in 21 studies (6 of the 34
studies with time-to-event outcomes and 15 of the 28
studies with binary outcomes). Among the 62 NNT-
reporting articles, 1 article used the term "number needed
to screen" (NNS), 2 articles used the terminology
"number needed to treat for one patient to benefit"
(NNTB) and harm (NNTH), respectively, and 1 article
used the term "number needed to harm" (NNH).
The absolute risk reduction was given in 33 (53.2%) of the
62 NNT-reporting articles (17 with time-to-event data and
16 with binary data), a corresponding confidence interval
for the absolute risk reduction was given in 21 (63.6%) of
33 articles (7 with time-to-event data and 14 with binary
data).
Discussion
The number needed to treat is used as effect measure to
present the results from randomised controlled trials with
binary and time-to-event outcomes. We found that in the
case of survival time data incorrect methods were frequently
applied. As the explanatory document of the CONSORT
statement [13] described the number needed to treat in addi-
Table 2: Reporting of the number needed to treat (NNT) and corresponding 95% confidence interval (CI) in randomised controlled 
trials (RCTs) with time-to-event outcomes in leading medical journals in the years 2003–2005
No. of articles
Journal RCTs with time-to-event data NNT Appropriate NNT calculation CI for NNT
BMJ 17 2 0 0
JAMA 89 9 4 2
Lancet 111 10 6 1
NEJM 156 13 7 3
Total 373 34 (9.1%) 17 (50%) 6 (17.6%)BMC Medical Research Methodology 2009, 9:21 http://www.biomedcentral.com/1471-2288/9/21
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tion to other effect measures (risk ratio or risk reduction) as
helpful for expressing results of both binary and survival
time data, appropriate methods are required for the calcula-
tion of NNTs also for the situation of time-to-event data. Our
finding that 50% of the NNT-reporting articles with survival
time data used inadequate calculation methods underlines
the requirement to point out that special methods based on
survival time techniques have to be used to calculate NNTs
in this situation. This observed proportion probably under-
estimates the true proportion because we classified the
method to calculate NNTs as "appropriate" if the method
used was unclear and the reported NNT equalled the recalcu-
lated NNT from survival probabilities. It could be that in fact
naive proportions have been used (i.e. an inappropriate
method) but the result haphazardly equalled the correct
result based upon survival probabilities. Thus, the true pro-
portion of NNT-reporting articles with survival time data and
inadequate calculation methods may be even higher than
the observed proportion of 50%. As the considered journals
represent the leading journals in medical research it can be
expected that a broader review containing also medical jour-
nals of lower rank would lead to even a higher proportion of
papers with inadequate NNT calculation.
In this paper we did not judge whether the application of
NNTs was helpful or useful in the specific situation. For
example, it was argued that in the case of chronic diseases
and continuous treatments the calculation of NNTs by
inverting the risk differences is not useful because the
duration of treatment is not taken into account [15]. We
agree that in the case of continuous treatments one should
be careful if a cost-effectiveness analysis shall be made on
the basis of NNTs. The treatment costs depend on the
duration of treatment and this is shorter than the follow-
up time for patients having an event before the end of the
study. Thus, simple NNTs are insufficient for cost-effec-
tiveness analyses in the case of chronic diseases and con-
tinuous treatments. If the duration of treatment is
important, more complicated methods are required, e.g.
survival techniques for time dependent covariates. These
methods are not considered in this paper because the
problem of treatment duration is independent from the
type of outcome (binary or time-to-event data). If the
treatment duration plays a role in the analysis, it has to be
considered in addition to the effect measure used, regard-
less of whether the effect measure is the NNT or any other
measure (risk difference, odds ratio, hazard ratio). In gen-
eral it is highly subjective whether NNTs are useful or not.
Therefore, we did not judge the usefulness of reported
NNTs in the specific situation but considered the fre-
quency of NNT applications in RCTs published in major
medical journals in the years 2003 to 2005 and verified
whether the applied calculation methods were technically
appropriate in the case of time-to-event outcomes.
Table 3: Reported and recalculated NNTs with 95% confidence intervals (CIs) from 17 studies using inappropriate methods to 
calculate NNTs for time-to-event data
No. Reported NNT Reported
95% CI
Recalculated NNT Recalculated
95% CI
Absolute difference
(reported NNT – 
recalculated NNT)
1 14 - 17.5 9.2 – 171.9 -3.5
2 23 - 18.2 11.1 – 49.6 +4.8
3 10 - 14.7 7.8 – 117.6 -4.7
4 40 - 57.1 NNTB 24.2 to ∞ to NNTH 156.6 -17.1
5 O1: 2.2
O2: 6.1
- O1: 2.0
O2: 4.5
O1: 1.7 – 2.7
O2: 2.8 – 15
O1: +0.2
O2: +1.6
6 TP1: 5–6
TP2: 12
TP1: 3.6 – 11.1
TP2: 6.3 – 74.6
*- -
7 138 77 – 641 * - -
8 38 - * - -
9 96  –  1 4* - -
10 O1: 40
O2: 118
-O 1 :  3 3 . 3
O2: 100.0
O1: 19.3 – 123
O2: NNTB 46.8 to ∞ to NNTH 
741.3
O1: +6.7
O2: +18.0
11 7.5 4.8 – 14.7 7.1 4.5 – 16.9 +0.4
12 39 - 38.2 21.7 – 158.1 +0.8
13 4.3 - 4.5 2.6 – 17.9 -0.2
14 5 - 4.9 3.7 – 7.1 +0.1
15 30 - * - -
16 "Slightly more than 6" - * - -
17 NNS = 352 - 325.7 185.4 – 1337.5 +26.3
* A recalculation of the NNT was not possible because no sufficient information about the required survival probabilities was presented.
CI = confidence interval; NNS = number needed to screen; NNTB = number needed to treat for one patient to benefit; NNTH = number needed 
to treat for one patient to be harmed; O = outcome; TP = time pointBMC Medical Research Methodology 2009, 9:21 http://www.biomedcentral.com/1471-2288/9/21
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The error produced by using an inadequate method to cal-
culate NNTs is unpredictable. In a number of cases, there
was no substantial difference between adequately and
inadequately calculated NNTs. For example, one trial with
inappropriate NNT calculation presented a number
needed to treat of 39 which is nearly the same as the cor-
rect result of 38.2 obtained by the appropriate method
proposed by Altman & Andersen [14]. However, in
another trial the published NNT of 23 is 26.4% too large
(absolute difference: +4.8) compared with the correct
result of 18.2. In another example the published NNT of
10 is 32% too small (absolute difference: -4.7) compared
with the correct result of 14.7 (Table 3). It has been argued
that clinicians should not be overly concerned about inac-
curacies that may arise from estimating NNTs inade-
quately from naive proportions, especially when using
data from large RCTs with high rates of follow-up [20]. We
agree that in the case of equal censoring in the two groups
the difference between adequately and inadequately cal-
culated NNTs is negligible in practice. However, if the
amount of censoring is quite different between the exper-
imental and control group, relevant differences between
adequately and inadequately calculated NNTs can be
obtained. Moreover, confidence intervals for NNTs will be
too narrow if censoring is not taken into account because
the values used for the effective sample sizes are too large.
This is demonstrated in Table 3 where the recalculated
confidence interval covers the reported confidence inter-
val completely. Unfortunately, there was only one study
in which a confidence interval for NNT was reported and
a recalculation of the confidence interval was possible. As
the application of survival techniques is standard in the
analysis of RCTs with varying follow-up times to account
for censoring there is no reason to accept inaccurate point
or interval estimates for NNTs due to neglecting censor-
ing.
According to the CONSORT statement [21] confidence
intervals should be reported for estimated effect measures
to indicate the precision of the estimates. Due to the unu-
sual scale of NNTs their confidence intervals are difficult
to describe if the effect is not significant [22]. This may be
one reason why confidence intervals for the number
needed to treat were given in one third of the investigated
articles only (time-to-event and binary data). Neverthe-
less, the methodology to calculate confidence intervals for
NNTs is described and explained in the statistical as well
as in the medical literature [12,22-27], so that the unusual
scale of NNTs should be no argument to disregard the
CONSORT statement.
Conclusion
In summary, there is much room for improvement in the
application of the number needed to treat to present
results of randomised controlled trials, especially where
the outcome is time to an event. To account for censoring
survival time techniques have to be used to calculate the
number needed to treat. The common standard to provide
confidence intervals to indicate the uncertainty of esti-
mated effect measures should also be applied to the
number needed to treat. In general, it should be carefully
considered whether the use of the number needed to treat
is sensible in the specific context. If the number needed to
treat is applied the use of correct calculation methods is
required as well as the presentation of point and interval
estimates.
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